Antithyroid Agents

Known as: Antithyroid Agent, Thyroid Antagonist, ANTITHYROID PREPARATIONS 
Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1945-2018
05010019452017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
BACKGROUND Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an… (More)
  • table 1
  • table 2
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Fetuses from mothers with Graves' disease may experience hypothyroidism or hyperthyroidism due to transplacental… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Serum cystatin C (CysC) is a novel marker for kidney function that has been claimed to be superior to serum creatinine… (More)
  • table 1
  • figure 2
  • table 2
  • figure 3
  • figure 1
Is this relevant?
Highly Cited
2001
Highly Cited
2001
There is little consensus regarding the most appropriate dose regimen for radioiodine (131I) in the treatment of hyperthyroidism… (More)
Is this relevant?
2000
2000
Hyperthyroid patients exhibit accelerated bone loss by increased bone turnover, and normalization of thyroid function is… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
CONTEXT High-dose iodine 131 is the treatment of choice in the United States for most adults with hyperthyroid disease. Although… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
To analyze the benefits and risks of three common treatments, we randomly assigned 179 patients with Graves' hyperthyroidism as… (More)
Is this relevant?
1994
1994
The roles of thyroid hormones and thyrotropin (TSH) in the development of Graves' ophthalmopathy are not clear. Some studies… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
BACKGROUND Ophthalmopathy caused by Graves' disease may first appear or worsen during or after treatment for hyperthyroidism. It… (More)
Is this relevant?
Highly Cited
1990
Highly Cited
1990
To study the protective effects of maternal thyroxine (T4) and 3,5,3'-triiodothyronine (T3) in congenital hypothyroidism, we gave… (More)
  • table I
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?